AR247197A1 - Procedimiento para preparacion de nuevos compuestos broncoespasmoliticos - Google Patents

Procedimiento para preparacion de nuevos compuestos broncoespasmoliticos

Info

Publication number
AR247197A1
AR247197A1 AR90316487A AR31648790A AR247197A1 AR 247197 A1 AR247197 A1 AR 247197A1 AR 90316487 A AR90316487 A AR 90316487A AR 31648790 A AR31648790 A AR 31648790A AR 247197 A1 AR247197 A1 AR 247197A1
Authority
AR
Argentina
Prior art keywords
formula
preparation
compound
spasmolytic
bronchi
Prior art date
Application number
AR90316487A
Other languages
English (en)
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Application granted granted Critical
Publication of AR247197A1 publication Critical patent/AR247197A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/58—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

UN PROCESO PARA LA PREPARACION DE UN COMPUESTO DE LA FORMULA (X) Y SALES FARMACEUTICAMENTE ACEPTABLES DEL MISMO, EN DONDE R1 Y R2 JUNTOS FORMAN LA CADENA -O-CH2-O- O -O-CF2-O-; R3 ES H O CH3; R5ES H O -CO-R7; R6 ES H,OH,OCH3,OC2H5 O HALOGENO; R7 ES ALQUILO, ARILO, -NHCH3 O -N(CH3)2, QUE COMPRENDE HACER REACCIONAR EL 4-BENCILOXI-3-NITRO-ESTIRENOXIDO DE LA FORMULA (V); CON UM COMPUESTO DE LA FORMULA (VI), EN DONDE R4 ES HIDROGENO O (I); PARA DAR UN COMPUESTO DE LA FORMULA (VII) SE HACE REACCIONAR CON HIDROGENO Y UN CATALIZADOR ADECUADO Y CON FORMULA (II), PARA RENDIR DESPUES DE LA HIDROGENACION UN COMPUESTO DE LA FORMULA (X) COMO UN ISOMERO PURO, UN RACEMATO O UNA MEZCLA DE ISOMEROS.
AR90316487A 1989-03-28 1990-03-28 Procedimiento para preparacion de nuevos compuestos broncoespasmoliticos AR247197A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8901060A SE8901060D0 (sv) 1989-03-28 1989-03-28 New compounds

Publications (1)

Publication Number Publication Date
AR247197A1 true AR247197A1 (es) 1994-11-30

Family

ID=20375454

Family Applications (1)

Application Number Title Priority Date Filing Date
AR90316487A AR247197A1 (es) 1989-03-28 1990-03-28 Procedimiento para preparacion de nuevos compuestos broncoespasmoliticos

Country Status (30)

Country Link
EP (1) EP0390762B1 (es)
JP (1) JPH02286650A (es)
KR (1) KR900014309A (es)
CN (1) CN1045968A (es)
AR (1) AR247197A1 (es)
AT (1) ATE100437T1 (es)
AU (1) AU618171B2 (es)
CA (1) CA2013114A1 (es)
CZ (1) CZ280747B6 (es)
DD (1) DD297805A5 (es)
DE (1) DE69006071T2 (es)
DK (1) DK0390762T3 (es)
EG (1) EG18954A (es)
ES (1) ES2062495T3 (es)
FI (1) FI901528A0 (es)
HK (1) HK123396A (es)
HR (1) HRP920765A2 (es)
HU (1) HUT58043A (es)
IE (1) IE64851B1 (es)
IL (1) IL93799A (es)
IS (1) IS1581B (es)
LT (1) LT3979B (es)
LV (1) LV10708B (es)
NO (1) NO172115C (es)
NZ (1) NZ232765A (es)
PL (1) PL163566B1 (es)
PT (1) PT93576B (es)
SE (1) SE8901060D0 (es)
YU (1) YU47508B (es)
ZA (1) ZA901716B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6040344A (en) 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
US6472563B1 (en) 2001-11-09 2002-10-29 Sepracor Inc. Formoterol tartrate process and polymorph
US7169907B2 (en) * 2002-03-01 2007-01-30 Roche Diagnostics Operations, Inc. Derivatives, immunogens, and antibodies for detecting ecstasy-class drugs
EP2348013A1 (en) * 2010-01-25 2011-07-27 Inke, S.A. Process for preparation of intermediates of arformoterol

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4072720A (en) * 1971-01-19 1978-02-07 Mobil Oil Corporation Production of alcohol
US3700692A (en) * 1971-06-04 1972-10-24 Colgate Palmolive Co 1-(4{40 -hydroxy-3{40 -(hydroxy methyl)-phenyl)-1-hydroxy-2-aralkylaminoethanes
GB1531718A (en) * 1974-11-20 1978-11-08 Pharmacia As Phenylethanolamines

Also Published As

Publication number Publication date
PT93576A (pt) 1990-11-07
YU46490A (en) 1992-05-28
NO172115C (no) 1993-06-09
HUT58043A (en) 1992-01-28
PL163566B1 (pl) 1994-04-29
AU5067590A (en) 1990-10-04
CZ151890A3 (en) 1995-12-13
ES2062495T3 (es) 1994-12-16
NO900982D0 (no) 1990-03-01
LT3979B (en) 1996-06-25
IE901104L (en) 1990-09-28
IS3567A7 (is) 1990-09-29
ZA901716B (en) 1990-12-28
EG18954A (en) 1994-03-30
AU618171B2 (en) 1991-12-12
IS1581B (is) 1996-03-01
CZ280747B6 (cs) 1996-04-17
DE69006071T2 (de) 1994-05-19
NO172115B (no) 1993-03-01
FI901528A0 (fi) 1990-03-27
IL93799A (en) 1994-12-29
DK0390762T3 (da) 1994-05-24
JPH02286650A (ja) 1990-11-26
LV10708B (en) 1996-02-20
EP0390762A1 (en) 1990-10-03
YU47508B (sh) 1995-10-03
LTIP1719A (en) 1995-07-25
HK123396A (en) 1996-07-19
DD297805A5 (de) 1992-01-23
NO900982L (no) 1990-10-01
SE8901060D0 (sv) 1989-03-28
CN1045968A (zh) 1990-10-10
CA2013114A1 (en) 1990-09-28
LV10708A (lv) 1995-06-20
KR900014309A (ko) 1990-10-23
IE64851B1 (en) 1995-09-06
PT93576B (pt) 1996-03-29
NZ232765A (en) 1992-12-23
HRP920765A2 (en) 1995-02-28
EP0390762B1 (en) 1994-01-19
HU901854D0 (en) 1990-08-28
ATE100437T1 (de) 1994-02-15
DE69006071D1 (de) 1994-03-03

Similar Documents

Publication Publication Date Title
CO4920223A1 (es) Derivados de 1,3,8-triaza-espiro[4,5]decan-4-ona 8- sustituidos
LU91587I2 (fr) Agomélatine et ses dérivés pharmaceutiquement acceptables (VALDOXAN)
KR830006174A (ko) 기관지 항경련성 화합물 제조방법
ES2044981T3 (es) Un proceso para la preparacion de nuevos derivados de 4(3h)-quinazolinona.
MX21088A (es) N-heteroanil-purin-6-aminas, y un proceso para su preparacion y su uso como medicamentos.
KR860003200A (ko) 테트라하이드로나프탈렌 유도체의 제조방법
AR247197A1 (es) Procedimiento para preparacion de nuevos compuestos broncoespasmoliticos
ES548204A0 (es) Un metodo para preparar un derivado de 1-piperazin-3-feni- lindano
MX9202975A (es) Nuevos compuestos biciclicos y sus sales farmaceuticamente aceptables y procedimiento para su preparacion.
ES2183492T3 (es) Nuevos derivados de nitrono,su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2054502T3 (es) Esteres del acido 10-(1-hidroxietil)-11-oxo-1-azatriciclo(7.2.0.0(3.8))-undec-2-en-2-carboxilico y un procedimiento para su preparacion.
ES2128554T3 (es) Nuevos derivados del acido glutamico, procedimiento para su preparacion y su utilizacion como medicamentos para el aumento de la memoria y aprendizaje.
GEP19970819B (en) Method of producing racemates of complex ethers of cis-and/or trans-apotartronic acid isomers thereof,possessing optical activity
SE9002596D0 (sv) A method for synthesis of prostaglandin derivatives
EA199600007A3 (ru) Новые трициклические производные, способ их получения, способы получения оптически активных или рацемических колхицина и тиоколхицина, их аналогов или производных с использованием трициклических соединений и промежуточные продукты синтеза
ES2019871B3 (es) 1,2,3,4,4a,9b-hexahidro-4a-aminoalquildibenzofuranos, un proceso para su preparacion y su uso como medicamentos.
DE3483881D1 (de) 1,3-dioxan-4-ylalkensaeure.
ES2053780T3 (es) Nuevos derivados 17-aza de 20,21-dinoreburnamenina y nuevos productos intermedios de preparacion, su aplicacion como medicamentos y composiciones que los contienen.
AR003927A1 (es) Derivados de cefalosporina, preparaciones farmaceuticas que los contienen, un procedimiento para su preparacion y su uso para la manufactura demedicamentos
ZA84261B (en) Bicyclo(4.2.0)1,3,5-octatriene derivatives,a process for their preparation and pharmaceutical compositions containing them
FR2476649B1 (es)
US3875163A (en) Nitrogen containing acyclic isoprenoid compounds
ES2038218T3 (es) Un procedimiento para preparar nuevos derivados de 2-alquilsulfinil-4(3h)-quinazolinona.
SE8205335D0 (sv) Nya 20,21-dinoreburnamenin-derivat, eventuellt substituerade pa e-ringen, forfarande och mellanprodukter for framstellning derav, anvendning derav sasom lekemedel samt kompositioner innehallande dem
ES2163036T3 (es) Nueva sintesis asimetrica de r y s warfarina y sus analogos.